Vulvovaginitis due to Candida glabrata. An emerging problem

Mycoses, Supplement

Volumn 41, Issue 2, 1998, Pages 18-22

  Sobel, Jack D ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Candida glabrata; Vaginitis; Vulvovaginitis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BORIC ACID; BUTOCONAZOLE; CLOTRIMAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; TERCONAZOLE;

CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL FEATURE; CONFERENCE PAPER; DRUG SENSITIVITY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SUPPOSITORY; VULVOVAGINITIS;

CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; VAGINITIS;

CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 0032418594     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Sobel, J. D., Faro, S., Force, R., et al. (1998) Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol 178, 203-211.
2. Lynch, M. E., & Sobel, J. D. (1994) Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J. Med. Vet. Mycol. 32, 267-274.
3. Cauwenbergh, G., (1990) Vaginal candidiasis: evolving trends in the incidence and treatment of non-Candida albicans infections. Curr. Probl. Obstet. Gynecol. Fertil 8, 241-245.
4. Fan-Havard, P., Capano, D., Smith, S. M., Mangia, A., & Eng, R. H. (1991) Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob. Agents. Chemother. 34, 2302-2305.
5. Lynch, M. E., Sobel, J. D., & Fidel, Jr., P. L. (1996) Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J. Med. Vet. Mycol 34, 337-339.
6. Schuman, P., Capps, L., Peng, G., et al (1997) Weekly fluconazole for the treatment of mucosal candidiasis in women with HIV infection. A randomized, double blind, placebo controlled trial. Ann. Intern. Med. 126, 689-696.
7. Schuman, P., Sobel, J. D., Ohmit, S., et al (1998) Mucosal Candida colonization and candidiasis in women with or without at-risk for HIV infection. Clin. Infect. Dis. (In press).
8. Spinillo, A., Capuzzo, E., Egbe, T., Baltaro, F., Nicola, S., and Piazzi, G. (1995) Torulopsis glabrata vaginitis. Obstet. Gynecol 85, 993-998.
9. Kwon-Chung, K. J., & Bennett, J. E. (1992) Candidiasis (Moniliasis, thrush, Candida paronychia, Candida endocarditis, bronchomycosis, mycotic vulvovaginitis, candidosis). In: Cann, C. (ed), Medical Mycology, Lea & Febiger, Philadelphia, London.
10. Sinnott IV,J. T. (1987) Candida (Torulopsis) glabrata. Infection Control 8, 334-336.
11. De Bernardis, F., Chiani, P., Ciccozzi, M., et al (1996) Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun. 64, 466-471.
12. Fidel, P. L., Cutright, J. L., Tait, L., & Sobel J. D. (1996) A murine model of Candida glabrata vaginitis. J. Infect. Dis. 173, 425-431.
13. Shakir, B. S., Martin, M. V., & Smith, C. J. (1983) Relative effectiveness of various yeasts, Candida spp. and Torulopsis glabrata, for inducing palatal infection in the Wistar rat. Arch Oral Biol. 28, 1069-1071.
14. Geiger, A. M., Foxman, B., & Sobel, J. D. (1995) Chronic vulvovaginal candidiasis: Characteristics of women with Candida albicans, Candida glabrata, and no Candida. Genitourin. Med. 71, 304-307.
15. Vazquez, J. E., Sobel, J. D., Schuman, P., Steele-Moore, L., Holloway, W., Neaton, J. Evaluation of vaginal Candida recovered from HIV-infected women receiving Fluconazole prophylaxis: The emergence of C. glabrata (In press).
16. Sobel, J. D., & Chaim, W. (1997) Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy. Clin Infect. Dis. 24, 649-652.
17. Redondo-Lopez, V., Lynch, M., Schmitt, C., Cook, R., & Sobel, J. D. (1990) Torulopsis glabrata vaginitis: Clinical aspects and susceptibility to antifungal agents. Obstet. Gynecol. 76, 651-655.